Roundup Settlement 2026: $7.25 Billion Bayer Class Action — How Much Will I Get and How to File
Steve Levine | Published: February 19, 2026
Settlement Amount: Up to $7.25 Billion
Status: Pending Court Approval (Filed February 17, 2026)
Average Payouts: $10,000 to $165,000 (Up to $198,000 with adjustments)
Court: 22nd Judicial Circuit Court, City of St. Louis, Missouri
Monsanto (owned by Bayer AG) has proposed a $7.25 billion class action settlement to resolve claims that its Roundup weed killer products cause non-Hodgkin lymphoma (NHL). The Roundup settlement was filed on February 17, 2026 in St. Louis Circuit Court and would pay individual awards ranging from $10,000 to $165,000 or more to people who used Roundup and developed NHL.
You May Also Be Able to File a Separate Individual Roundup Lawsuit
In addition to the $7.25 billion class action settlement described on this page, you may also have the option to pursue an individual Roundup lawsuit with your own attorney. This is a completely separate legal path from the class settlement. Many Roundup plaintiffs who filed their own individual lawsuits have received jury awards far higher than the class settlement amounts — including verdicts of $289 million, $332 million, and $2.1 billion.A free case review lets you speak with a Roundup attorney who can look at your specific situation and explain whether the class settlement, an individual lawsuit, or both may be right for you. There is no cost and no obligation.
Free Case Review
The $7.25 Billion Roundup class action settlement is the largest Roundup settlement to date, and one of the largest in history. It covers both people who have already been diagnosed with NHL and people who were exposed to Roundup but have not yet been diagnosed. If you used Roundup or other glyphosate-based weed killers at home, at work, or on a farm in the United States, you may qualify for a payment from this Bayer Roundup settlement.
The court has not yet granted preliminary approval. A hearing date has not been set. Once approved, the claims process will begin. This page covers everything you need to know about the Roundup settlement: who qualifies, how much you could receive, how to file, and key deadlines.
Read the Full Roundup Settlement Agreement (PDF)
Who Qualifies for the Roundup Settlement?
The Roundup class action settlement covers U.S. persons who were exposed to Roundup Products in the United States before February 17, 2026. You qualify if you applied the products yourself, purchased or paid for the products or their application, participated in or directed the application of the products, or otherwise had reason to know you were exposed.You do not need to be a U.S. citizen to participate. Your immigration status does not affect eligibility. The Roundup settlement covers exposure in all 50 states, the District of Columbia, Puerto Rico, Guam, American Samoa, the U.S. Virgin Islands, the Northern Mariana Islands, and at U.S. military or diplomatic establishments worldwide.
The settlement class is divided into two subclasses:
Subclass 1 includes people already diagnosed with NHL as of the date of preliminary approval. These claimants can register and file claims once the settlement is approved.
Subclass 2 includes people who were exposed to Roundup Products but have not yet been diagnosed with NHL. Subclass 2 members are part of the settlement now but can only file a claim if they are diagnosed with NHL in the future — within 6 years of diagnosis or before the 16th Annual Payment Date, whichever comes first.
Derivative claimants such as spouses, parents, or dependent children of exposed persons are also included. Legal representatives, executors, or administrators acting on behalf of deceased or incapacitated exposed persons may file claims as representative claimants.
Roundup Settlement Payout: How Much Will I Get?
The Roundup settlement uses a 9-tier system to determine individual awards. Your payout depends on three factors: whether you are an occupational or residential claimant, your age at NHL diagnosis, and whether your NHL subtype is aggressive or indolent. Within each tier, individual awards may be adjusted from 80% to 120% of the tier average based on claim-specific factors.Here is the full Roundup settlement payout breakdown by tier:
| Roundup Settlement Payout Tiers | |||
| Exposure Type | Age at Diagnosis | NHL Type | Average Award |
|---|---|---|---|
| Occupational | Under 60 | Aggressive | $165,000 |
| Occupational | 60 to 77 | Aggressive | $105,000 |
| Occupational | Under 60 | Indolent | $85,000 |
| Occupational | 60 to 77 | Indolent | $60,000 |
| Residential | Under 60 | Aggressive | $40,000 |
| Residential | 60 to 77 | Aggressive | $30,000 |
| Residential | Under 60 | Indolent | $25,000 |
| Residential | 60 to 77 | Indolent | $20,000 |
| Any | 78 or older | Any | $10,000 |
These are tier averages. Individual awards may range from 80% to 120% of the average based on claim-specific scoring factors. That means the highest possible individual award under the standard program is approximately $198,000 (120% of the $165,000 top tier). Additional compensation may be available through the Extraordinary Circumstances Fund for claimants with severe medical outcomes.
Keep in mind that individual Roundup lawsuits have resulted in jury awards far exceeding these class settlement amounts. An attorney can help you decide whether opting out and filing your own case makes sense.
Free Case Review
Occupational vs. Residential Roundup Claimants
Your classification as an occupational or residential claimant determines your payout tier. The distinction matters because occupational claimants typically had more intense and prolonged exposure to Roundup and receive higher average awards.Occupational claimants are people who were exposed to Roundup Products for more than 80 hours while working in an agricultural, industrial, turf, or ornamental capacity. They must have earned more than 50% of their income or more than $15,000 from the relevant job in at least one year. Examples include farmers, farm laborers, gardeners, maintenance workers, landscapers, pesticide applicators, groundskeepers, lawn service workers, tree trimmers, highway and rail maintenance workers, and facilities managers. Occupational claimants must provide documentary evidence such as employment records, payroll records, business licenses, or tax records.
Residential claimants are people who were exposed to Roundup Products at home or in a non-occupational setting. This includes homeowners who used the product for gardening, landscaping, weed control on driveways or patios, or general use around the home. Residential claimants need at least 16 hours or 10 lifetime days of exposure. Attestation alone is sufficient to prove residential exposure — no documentary proof is required.
What Factors Affect Your Roundup Settlement Payout?
Within each tier, individual Roundup settlement awards are adjusted upward or downward based on several claim-specific factors.Factors that may increase your award include younger age at diagnosis, stronger proof of exposure such as photos or purchase receipts, greater duration or frequency of exposure, more intensive treatment including chemotherapy or radiation, Stage IV diagnosis, and diagnosis occurring 5 to 15 years after the exposure window.
Factors that may decrease your award include older age at diagnosis, weaker proof of exposure, an AIDS diagnosis, prior organ transplant, prior blood cancer, immunosuppressant use, prior Hepatitis C or Epstein-Barr virus for certain NHL subtypes, and other alternative causation explanations.
Quick-Pay Option for Roundup Claimants
Residential claimants and claimants diagnosed at age 78 or older may be eligible for the Quick-Pay option. Quick-Pay provides faster, reduced payments for claimants who prefer not to wait for full program processing.Quick-Pay amounts range from $6,000 to $14,500 depending on tier placement. Quick-Pay is only available to Initial Claimants who filed a lawsuit or tolling agreement before February 13, 2026. Accepting a Quick-Pay Award means you cannot receive a standard program award.
Additional Roundup Settlement Compensation
The Roundup settlement includes several additional funds for claimants with special circumstances.The Extraordinary Circumstances Fund provides additional payments for claimants who experienced severe medical outcomes including death before age 78, organ transplant, CAR-T therapy, intrathecal chemotherapy, or Stage IV diagnosis. This fund receives up to 5% of each annual payment.
The Extraordinary Residential Exposure Fund provides extra compensation for residential claimants who had significant exposure, defined as 80 or more hours on properties totaling 6 or more acres. This fund receives 1.5% of each annual payment. Documentary proof is required.
Exigency Awards are available before the settlement becomes final for claimants facing imminent housing loss or who have a terminal condition. These awards are funded at up to $20 million per year for the first 3 years.
How to File a Roundup Settlement Claim
The claims process has not started yet because the court has not granted preliminary approval. Once the settlement is approved, here is how the process will work:Subclass 1 (Already Diagnosed with NHL): Register within 180 days of final approval. Submit your full claim within 180 days of the effective date (after any appeals are resolved).
Subclass 2 (Not Yet Diagnosed): You do not need to register now. If you are diagnosed with NHL in the future, file a claim within 6 years of your diagnosis or before the 16th Annual Payment Date, whichever comes first.
The claims administrator for the Roundup settlement is BrownGreer PLC. Visit WeedKillerClass.com for updates on when the claims process will open.
Key Deadlines for the Roundup Settlement
• Preliminary Approval: Not yet granted. Hearing date to be determined.• Registration Deadline (Subclass 1): 180 days after final approval
• Claim Submission Deadline (Subclass 1): 180 days after the effective date
• Claim Deadline (Subclass 2): Within 6 years of NHL diagnosis or before 16th Annual Payment Date
• Opt-Out Deadline: 90 days after notice begins (date to be determined)
• Objection Deadline: To be determined
• First Payment: $500 million within 10 business days of preliminary approval
• Second Payment: $500 million by August 31, 2026
How the Roundup Settlement Fund Works
Monsanto will pay up to $7.25 billion over 17 to 21 years. The first $1 billion is front-loaded in the first year. After that, Monsanto will make 16 annual payments ranging from $550 million down to $250 million per year. An inflation adjustment of up to 2.5% annually begins in year 5.A separate $1 billion security fund serves as a bankruptcy backstop. If Monsanto enters bankruptcy and fails to make payments, the security fund is liquidated and distributed to class members. Additional extended funding of up to $1 billion over 4 extra years is available if needed for remaining occupational claimants.
Attorney fees are paid from the settlement fund. Individual attorneys who represent specific claimants are capped at 22% of the claimant's award.
What You Give Up by Staying in the Roundup Settlement
By staying in the Roundup settlement, you release all compensatory, punitive, and medical monitoring claims against Monsanto, Bayer, and related parties. However, the settlement includes several exit provisions:Subclass 2 members who applied for Extraordinary Circumstances Fund awards can reject their award after reconsideration and exit the settlement. Any claimant who waits 5 or more years from their claim eligibility date without receiving payment can exit. Exiting class members receive a $500 payment, retain the right to sue for compensatory damages, but are permanently barred from seeking punitive damages.
Class members who are never diagnosed with NHL by the 16th annual payment date get all their legal rights restored, including the right to seek punitive damages.
How to Opt Out or Object to the Roundup Settlement
If you want to keep your right to sue Monsanto on your own, you must exclude yourself from the settlement during the opt-out period. You will have 90 days after the notice period begins to opt out. The specific deadline has not been set yet. If you opt out, you will not receive any money from this Roundup settlement but you keep the right to file your own lawsuit.If you want to stay in the settlement but believe its terms are unfair, you can file an objection. The court will consider all objections before deciding whether to approve the Roundup settlement. Objection deadlines have not been set.
Monsanto has the right to terminate the settlement if too many people opt out.
Background: Roundup Lawsuits and Bayer's Litigation History
Monsanto (acquired by Bayer in 2018 for $63 billion) has been battling Roundup cancer lawsuits for more than a decade. The core allegation is that glyphosate, the active ingredient in Roundup, causes non-Hodgkin lymphoma and that Monsanto failed to warn users of the risk.In 2015, the International Agency for Research on Cancer (IARC) classified glyphosate as "probably carcinogenic to humans." The U.S. EPA maintains that glyphosate is not likely carcinogenic when used as directed. This scientific disagreement is central to the litigation.
Juries have repeatedly sided with plaintiffs in Roundup trials, delivering massive verdicts including $289 million in 2018 (Dewayne Johnson), $80 million in 2019 (federal), $2 billion in 2019 (California, Pilliod couple), $332 million in 2023 (California), $2.25 billion in 2025 (consolidated), and $2.1 billion in 2025 (Georgia). Bayer has paid more than $11 billion in prior settlements and verdicts.
In January 2026, the U.S. Supreme Court agreed to hear Monsanto Co. v. Durnell (Case No. 24-1068), which asks whether federal pesticide labeling law (FIFRA) preempts state failure-to-warn claims when the EPA has not required a cancer warning. A ruling in Monsanto's favor could significantly limit or dismiss current and future Roundup lawsuits. The settlement was designed in part to lock in compensation before that Supreme Court decision, which is expected in 2027.
Bayer currently faces approximately 61,000 to 67,000 active Roundup claims. In addition to this $7.25 billion class settlement, Bayer has separately resolved approximately $3 billion in individual cases, including the $2.1 billion Georgia verdict.
Settlement Administration
The Roundup settlement is administered by BrownGreer PLC, which processes all claims. Matthew Garretson of Garretson LLC handles claim scoring and tier assignment. Judge Glenn A. Norton serves as the Settlement Special Master overseeing the process. Wolf Global Compliance handles healthcare lien resolution. JPMorgan Chase Bank N.A. is the settlement fund escrow agent.Fraud Prevention
The Roundup settlement includes audit provisions to prevent fraudulent claims. The administrator will audit at least 2% of attestation-only claims annually and a minimum of 30 claims per quarter. Suspicious patterns may trigger additional investigation. Penalties include claim denial, attorney disqualification, and referral to authorities. Law firms with two or more knowing fraudulent submissions are permanently barred from the program.Roundup Supreme Court Case: Monsanto v. Durnell
The Roundup settlement was announced at a critical time in the litigation. In January 2026, the U.S. Supreme Court agreed to hear Monsanto Co. v. Durnell (Case No. 24-1068), which asks whether the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) preempts state failure-to-warn claims when the EPA has not required a cancer warning on the product label.The case originated from a 2023 jury verdict in St. Louis that awarded $1.25 million to John Durnell, who developed non-Hodgkin lymphoma after spraying Roundup on a community garden. The Missouri Court of Appeals upheld the verdict in February 2025, and the Missouri Supreme Court declined to review it. Oral arguments at the U.S. Supreme Court are scheduled for late April 2026, with a decision expected by mid-2027.
The Trump administration's U.S. Solicitor General John Sauer filed a brief supporting Bayer's position that federal law preempts state failure-to-warn claims. If the Supreme Court rules in Monsanto's favor, it could significantly limit or dismiss existing and future Roundup lawsuits nationwide.
This settlement was designed in part to lock in guaranteed compensation for claimants before that Supreme Court decision. Under the settlement, claimants receive payment regardless of the Supreme Court outcome. This is a key reason attorneys for both current and future claimants have urged participation.
Bayer's Financial Situation and Roundup Litigation Costs
Bayer acquired Monsanto in 2018 for $63 billion. Since then, Roundup litigation has cost the company more than $11 billion in settlements and verdicts. As of February 2026, approximately 200,000 Roundup-related claims have been made against Bayer, including more than 125,000 plaintiffs who filed suit since 2015. About 65,000 plaintiffs remain active in U.S. state and federal courts.Bayer has increased its total litigation reserves from 7.8 billion euros ($9.24 billion) to 11.8 billion euros ($13.9 billion) following this settlement proposal. The company expects approximately 5 billion euros in litigation-related payouts in 2026 and anticipates negative free cash flow for the year. To finance the settlement, Bayer secured an $8 billion bank loan facility.
Bayer's market capitalization has dropped from roughly $63 billion at the time of the Monsanto acquisition to approximately $25-26 billion as of early 2026. Bayer shares rose as much as 7.7% on the day of the settlement announcement, reaching their highest level since September 2023.
Only 24 Roundup cases have reached jury verdict, with 13 verdicts for Bayer and 11 for plaintiffs. Plaintiff verdicts have included massive awards: $289 million (Dewayne Johnson, 2018), $80 million (federal, 2019), $2 billion (Pilliod couple, California 2019), $332 million (single plaintiff, California 2023), $175 million (Pennsylvania, 2025), $2.25 billion (consolidated, 2025), and $2.1 billion (Georgia, 2025).
Glyphosate and Cancer: What the Science Says
Glyphosate is the active ingredient in Roundup and the most widely used herbicide in the world. Monsanto patented glyphosate in 1971 and introduced Roundup in 1974.In 2015, the International Agency for Research on Cancer (IARC), a division of the World Health Organization, classified glyphosate as "probably carcinogenic to humans" (Group 2A). A 2019 University of Washington meta-analysis found that individuals with high exposure to glyphosate had a 41% higher risk of developing non-Hodgkin lymphoma.
The U.S. Environmental Protection Agency (EPA) maintains that glyphosate is "not likely to be carcinogenic to humans" when used as directed. The federally approved label for Roundup includes no cancer warning. This scientific disagreement between IARC and the EPA is central to both the litigation and the pending Supreme Court case.
Roundup products are still sold in the United States for agricultural and commercial use. Bayer stopped selling glyphosate-based Roundup for residential (homeowner) use in 2023 and is currently seeking approval for a replacement herbicide in the U.S., Europe, Canada, Australia, and Brazil.
Types of Non-Hodgkin Lymphoma Covered by the Roundup Settlement
The Roundup settlement covers all subtypes of non-Hodgkin lymphoma (NHL). NHL is a cancer that develops in the lymphatic system, specifically in white blood cells called lymphocytes. There are more than 60 recognized subtypes of NHL, and they are broadly categorized as aggressive (fast-growing) or indolent (slow-growing). Your NHL subtype affects which payout tier you fall into.Aggressive NHL subtypes include diffuse large B-cell lymphoma (DLBCL), which is the most common form of NHL and accounts for roughly 30% of all NHL diagnoses. Other aggressive subtypes include mantle cell lymphoma, Burkitt lymphoma, and peripheral T-cell lymphomas.
Indolent NHL subtypes include follicular lymphoma, which is the second most common form of NHL, and chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL). Indolent lymphomas grow slowly but can transform into aggressive forms over time.
The settlement does not cover other types of cancer. Only non-Hodgkin lymphoma qualifies.
Previous Roundup Settlements and Verdicts
This is not the first attempt to resolve Roundup litigation through a class settlement. In 2020, Bayer announced a $10.9 billion settlement to resolve approximately 125,000 existing claims. That settlement was largely successful for pending cases, but a separate $2 billion fund for future claims was rejected by federal Judge Vince Chhabria in the Northern District of California MDL in 2021.This new $7.25 billion settlement addresses the gap left by that rejection. It includes both current claimants and a structured program for future claimants who have not yet been diagnosed. The settlement was negotiated over approximately 18 months with the assistance of a mediator, according to court documents.
In addition to this class settlement, Bayer has separately resolved approximately $3 billion in individual cases, including the resolution of the $2.1 billion Georgia verdict and settlements with multiple law firms handling high volumes of claims.
Frequently Asked Questions About the Roundup Settlement
Can I file a Roundup settlement claim right now?
Not yet. The court has not granted preliminary approval. Once approved, claim forms and registration procedures will be available through the official settlement website at WeedKillerClass.com.I used Roundup at home but was never diagnosed with cancer. Am I still part of the settlement?
Yes. You are automatically included in Subclass 2 (future claimants) if you were exposed to Roundup in the U.S. before February 17, 2026. You cannot file a claim for payment unless and until you are diagnosed with NHL. If you are never diagnosed with NHL by the 16th annual payment date, all of your legal rights are restored.What types of NHL does the Roundup settlement cover?
The settlement covers non-Hodgkin lymphoma (NHL) only. This includes aggressive subtypes such as diffuse large B-cell lymphoma (DLBCL), mantle cell lymphoma, and Burkitt lymphoma, as well as indolent subtypes such as follicular lymphoma, chronic lymphocytic leukemia (CLL), and peripheral T-cell lymphomas. No other cancers are covered.What if I already have a Roundup lawsuit pending?
If you already have a Roundup lawsuit or tolling agreement filed before February 13, 2026, you are considered an "Initial Claimant" and may be eligible for the Quick-Pay option. You are included in the settlement class unless you choose to opt out.Is Roundup still being sold?
Yes. Roundup products are still sold in the United States for agricultural and commercial use. Bayer stopped selling glyphosate-based Roundup for residential use in 2023. Existing products remain widely available in stores and for professional applications.Do I need a lawyer to file a Roundup claim?
You are not required to have a lawyer to file a claim, but having an attorney can help maximize your award and navigate the claims process. Attorney fees for individual representation are capped at 22% of your award under the settlement terms.Can family members file a Roundup claim for a deceased loved one?
Yes. Legal representatives, executors, or administrators acting on behalf of deceased or incapacitated exposed persons may file claims as representative claimants. Derivative claimants such as spouses, parents, or dependent children of exposed persons are also included in the settlement class.Does my immigration status affect my eligibility?
No. The settlement covers all persons exposed to Roundup Products in the United States, regardless of citizenship or immigration status.What if the Supreme Court rules in Bayer's favor?
If the Supreme Court rules that federal law preempts state failure-to-warn claims in Monsanto v. Durnell, it could limit or dismiss Roundup lawsuits filed in state courts. However, if you are part of this settlement class, you are entitled to your settlement payment regardless of the Supreme Court outcome. This is one of the primary reasons attorneys are recommending participation in the settlement.What happens if Monsanto goes bankrupt?
The settlement includes a $1 billion security fund that serves as a bankruptcy backstop. If Monsanto enters bankruptcy and fails to make settlement payments, the security fund is liquidated and distributed to class members. This provides a layer of protection for claimants.Talk to a Roundup Lawyer About Your Options
Not sure whether the class settlement or an individual lawsuit is better for you? A free case review takes just a few minutes. A Roundup attorney can look at your situation and walk you through your options at no cost.Free Case Review
Sources and References
• Official Settlement Website: WeedKillerClass.com• Full Settlement Agreement (PDF)
• Fortune: Bayer reaches $7.25 billion settlement over claims that Roundup caused cancer (AP/David A. Lieb)
• CBS News: Bayer proposes $7.2 billion settlement to resolve Roundup weedkiller cases
• Reuters/Yahoo Finance: Bayer proposes $7.25 billion plan to settle Roundup cancer cases
• Fox Business: Bayer proposes $7.25B plan to settle Roundup cancer lawsuits
• The New Lede: Bayer proposes $7.25 billion class action settlement
• St. Louis Public Radio: Proposed $7.25 billion Roundup settlement would cover cancer claims
• Fast Company: Bayer proposes $7.25 billion Roundup settlement as Supreme Court case looms
• AgWeb: Bayer Proposes Class Settlement Deal in Monsanto's Roundup Litigation
• Farm Policy News (University of Illinois): Bayer Proposes $7.25 Billion Roundup Settlement
• Motley Rice: National Roundup Class Settlement Agreement Reached
• Holland Law Firm: Monsanto Agreement to Pay Up to $7.25 Billion
• First Alert 4 (CBS affiliate): Bayer agrees to $7.25 billion settlement
• BrownGreer PLC: Roundup Settlements (Claims Administrator)
• Case: Monsanto Company Roundup Products Liability Settlement, 22nd Judicial Circuit Court, City of St. Louis, Missouri
• Monsanto Co. v. Durnell, No. 24-1068 (U.S. Supreme Court, cert. granted Jan. 16, 2026)
Roundup Settlement Claim Information
This page is for informational purposes. OpenClassActions.com is not a law firm, not a claims administrator, and does not represent any party in this litigation. For legal advice, speak with an attorney licensed in your state.How Do I Find Class Action Settlements?
Find all the latest class actions you can qualify for by getting notified of new lawsuits as soon as they are open to claims:
For more open class actions keep scrolling below.
Bayer Proposes $7.25 Billion RoundUp Cancer Settlement
Status: Open to Claims
Submit Claim
$25 Amazon Gift Card
Enter Here
Video Game Addiction Lawsuit
Deadline: Pending
Submit Claim
DraftKings & FanDuel Addiction Lawsuits
Status: Open
Submit Claim
Amazon Prime - 30 Days Free
Status: Active
Sign Up
Children playing Roblox and using Discord?
Pre-Qualify Here
Submit Claim
$4.17M RevitaLash Conditioner Settlement
Deadline: April 20, 2026
Submit Claim
$87.5M Beef Prices Settlement
Deadline: June 30, 2026
Submit Claim
Dollar General Bait & Switch Settlement
Deadline: April 13, 2026
Submit Claim
$3M Zoa Energy Drink Class Action Settlement
Deadline: Feb 20, 2026
File Claim
Belkin Power Bank Settlement
Deadline: March 30, 2026
Submit Claim
$4.85M Bayer Antifungal Spray Settlement
Deadline: March 11, 2026
Submit Claim
Michael Kors Outlet Class Action Settlement
Deadline: March 6, 2026
Submit Claim
Balance of Nature $9.95M Class Action
Deadline: March 11, 2026
Submit Claim| Roundup Settlement Summary | |
| Settlement Amount | Up to $7.25 Billion |
|---|---|
| Filed | February 17, 2026 |
| Court | 22nd Judicial Circuit Court, City of St. Louis, Missouri |
| Defendant | Monsanto Company (Bayer AG) |
| Who Qualifies | U.S. persons exposed to Roundup Products before Feb. 17, 2026 who have or develop NHL |
| Average Payouts | $10,000 – $165,000 (up to $198,000 with adjustments) |
| Quick-Pay | $6,000 – $14,500 (residential and age 78+ claimants) |
| Payment Period | 17 to 21 years |
| Opt-Out Period | 90 days after notice (date TBD) |
| Claims Administrator | BrownGreer PLC |
| Attorney Fee Cap | 22% of individual award |
| Settlement Website | WeedKillerClass.com |